Meditech
This article was originally published in The Tan Sheet
Executive Summary
Clinical trials comparing Zorex topical cold sore formula against two competitive products will be conducted by Boston University, Scottsdale, Ariz.-based firm announces. Clinicals are expected to last six months; if successful, results will be used to support advertising, marketing claims for Zorex, which contains monographed ingredient for pain, cold sore symptoms, as well as MTCH-24 compound. Meditech delaying regional launch of Zorex pending negotiations with five pharmaceutical companies (1"The Tan Sheet" April 2, In Brief)